US Patent 11247981 Metalloenzyme inhibitor compounds
Patent 11247981 was granted and assigned to Mycovia Pharmaceuticals on February, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Article (+195 characters)
Article
Patent abstract
The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Robert J. Schotzinger0
Stephen W. Rafferty0
William J. Hoekstra0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
112479810
Date of Patent
February 15, 2022
0Patent Application Number
167350940
Date Filed
January 6, 2020
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 2 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 26 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 16 Feb, 2022
Golden AI
Edits made to:
Infobox (+12 properties)
US Patent 11247981 Metalloenzyme inhibitor compounds
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11247981
Date of patent
February 15, 2022
Patent application number
16735094
Date Filed
January 6, 2020
Patent citations
Patent primary examiner
Find more entities like US Patent 11247981 Metalloenzyme inhibitor compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
